Some of us had been saying for quite awhile that at any price above $0.05, MJNA was overpriced, so I guess that before today's mid-day PR, MJNA was approaching a fair price, though till not undervalued.
Check out my post from nearly two months ago where I forcasted MJNA 2014 revenues between $14M and $15M and a $1M-$2M loss (I was too generous forecasting the loss).
So now I think that anything above $0.03 is overpriced, and once the reality of the dilution hits, along with some analysis of the results, MJNA will continue to fall.